<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>SGC Univ. of Toronto &#8211; openlabnotebooks.org</title>
	<atom:link href="https://thesgc.github.io/static-openlabnotebooks/category/laboratory/sgc-toronto/feed/" rel="self" type="application/rss+xml" />
	<link>https://thesgc.github.io/static-openlabnotebooks/</link>
	<description>A growing team of groundbreaking scientists around the world are now sharing their lab notebooks online</description>
	<lastBuildDate>Fri, 27 Sep 2019 13:24:29 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=4.9.11</generator>

<image>
	<url>https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2018/01/cropped-lab-jar02-32x32.png</url>
	<title>SGC Univ. of Toronto &#8211; openlabnotebooks.org</title>
	<link>https://thesgc.github.io/static-openlabnotebooks/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Purification of HTT N-HEAT_81-1643</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/purification-of-htt-n-heat_81-1643/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/purification-of-htt-n-heat_81-1643/#respond</comments>
		<pubDate>Fri, 27 Sep 2019 13:24:29 +0000</pubDate>
		<dc:creator><![CDATA[Claudia Alvarez]]></dc:creator>
				<category><![CDATA[Claudia Alvarez]]></category>
		<category><![CDATA[Huntingtin]]></category>
		<category><![CDATA[Huntington’s disease]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3587</guid>
		<description><![CDATA[It’s being a while since I wrote my first post. I have been busy in the lab trying to isolate monomeric and stable samples of the N-HEAT domain just as we demonstrated with the C-HEAT domain (and by Dr. Rachel Harding). In this post, I summarize the results of the first round of purification of <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/purification-of-htt-n-heat_81-1643/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>It’s being a while since I wrote my first post. I have been busy in the lab trying to isolate monomeric and stable samples of the N-HEAT domain just as we demonstrated with the <a href="https://thesgc.github.io/static-openlabnotebooks/purification-of-the-htt-c-heat-domain/">C-HEAT</a> domain (and by <a href="https://zenodo.org/record/2628060#.XYzlUmYpDb0">Dr. Rachel Harding)</a>.</p>
<p>In this post, I summarize the results of the first round of purification of the huntingtin N-HEAT domain with boundaries 81-1643 (<a href="https://zenodo.org/record/3462496#.XYzkY2YpDb0">HTT N-HEAT_81-1643</a>).</p>
<p>The construct HTT N-HEAT_81-1643 encompasses the entire N &#8211; terminal HEAT domain (all 21 HEAT repeats) (Figure 1). This construct and a few others N-HEAT constructs (which I will be posting about later) were selected among several N-HEAT constructs initially made due to high levels of expression in Sf9 cells (<a href="https://zenodo.org/record/2600051#.XKU89aeZPOQ">Dr. Rachel Harding</a>). The first large scale purification of HTT N-HEAT_81-1643 showed this construct elutes early from the Superdex 200 10/300 column (<a href="https://zenodo.org/record/2628060#.XULMtnspDb0">Dr. Rachel Harding</a>). This implied the construct was either in a high oligomeric state or an extended conformation.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/HTT_N-HEAT_B08_illustrator_2-e1569590474153-300x244.png" alt="" class="wp-image-3607 aligncenter" width="330" height="268" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/HTT_N-HEAT_B08_illustrator_2-e1569590474153-300x244.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/HTT_N-HEAT_B08_illustrator_2-e1569590474153-768x624.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/HTT_N-HEAT_B08_illustrator_2-e1569590474153-1024x833.png 1024w" sizes="(max-width: 330px) 100vw, 330px" /></p>
<p>Figure 1. Hunting structure (PDB 6ez8)<sup>1</sup>. N-HEAT (91-1641) colored in cyan</p>
<p>In <a href="https://zenodo.org/record/3462496#.XYzkY2YpDb0">this purification</a>, I used a different gel filtration column (Superpose 6 10/300) which has a broader fractionation range of MW weights than the Superdex 200 column used initially. By using this column, I could better idea of the particle size of HTT N-HEAT construct. The results from this purification showed the construct also eluted early from the Superose 6 column (MW ~670 KDa- according to protein standards). Note that, if the construct was a monomer and had globular shape, it should a elute at a volume of around 16 &#8211; 17 mL (the monomer = 172 KDa). The gel filtration results imply that the construct is in a high oligomeric state likely a tetramer. However, it is still also possible that the construct is in an extended conformation and this would also result in an early elution volume from the gel filtration column (large hydrodynamic ratio). Yet another possible explanation is that HTT N-HEAT_81-1643 is in a complex with nucleic acid material as final A<sub>260/280</sub> readings of the purified samples of the HTT N-HEAT_81-1643 show high content of nucleic acid material (A<sub>260/280</sub> = 0.7). Future experiments with this HTT N-HEAT_81-1643 will aim at testing these hypotheses.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190603_N-term-HTT-B08-superose_2-e1569590429899-300x174.png" alt="" class="size-medium wp-image-3609 aligncenter" width="300" height="174" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190603_N-term-HTT-B08-superose_2-e1569590429899-300x174.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190603_N-term-HTT-B08-superose_2-e1569590429899-768x445.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190603_N-term-HTT-B08-superose_2-e1569590429899-1024x594.png 1024w" sizes="(max-width: 300px) 100vw, 300px" /></p>
<p>Figure 2. Gel filtration profile N-HEAT_81-1643 using a Superose 6 10/300 column. Elution volume of construct N-HEAT_81-1643 is 12.6 mL.</p>
<p>The sample that was obtained from this purification was used to set crystal trays and to test sample stability. To date, no crystals have been observed in any of the trays set for this construct. Regarding the sample stability, the samples are easily degraded at 4 °C in comparison with the <a href="https://thesgc.github.io/static-openlabnotebooks/purification-of-the-htt-c-heat-domain/">C-HEAT</a> domain.</p>
<ol>
<li>Guo, Q.; Huang, B.;  Cheng, J. D.;  Seefelder, M.;  Engler, T.;  Pfeifer, G.;  Oeckl, P.;  Otto, M.;  Moser, F.;  Maurer, M.;  Pautsch, A.;  Baumeister, W.;  Fernandez-Busnadiego, R.; Kochanek, S., The cryo-electron microscopy structure of huntingtin. <em>Nature </em><strong>2018,</strong> <em>555</em> (7694), 117-+.</li>
</ol>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/purification-of-htt-n-heat_81-1643/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HDAC11 cellular assay development- histones deacetylation</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/hdac11-cellular-assay-development-histones-deacetylation/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/hdac11-cellular-assay-development-histones-deacetylation/#respond</comments>
		<pubDate>Tue, 24 Sep 2019 19:27:04 +0000</pubDate>
		<dc:creator><![CDATA[Magdalena Szewczyk]]></dc:creator>
				<category><![CDATA[HDACs]]></category>
		<category><![CDATA[Magdalena Szewczyk]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3558</guid>
		<description><![CDATA[In my previous post I mentioned that there is controversy if HDAC11 can deacetylate histones. I decided to look at the effect of overexpression of HDAC11 on exogenous histone acetylation in cells. In my preliminary results I noticed that exogenous GFP-tagged histones, one day post transfection, have very low levels of acetylation; therefore I decided <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/hdac11-cellular-assay-development-histones-deacetylation/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>In my previous post I mentioned that there is controversy if HDAC11 can deacetylate histones. I decided to look at the effect of overexpression of HDAC11 on exogenous histone acetylation in cells. In my preliminary results I noticed that exogenous GFP-tagged histones, one day post transfection, have very low levels of acetylation; therefore I decided to add to the system some histone acetyltransferases (p300, GCN5, MYST1, PCAF). My results indicate that overexpression of HDAC11 decrease basal acetylation levels of exogenous histones as well as decrease the acetylation increase caused by histone acetyltransferases. Since we do not know if the observed effect is caused by catalytic activity of HDAC11, I generated catalytic HDAC11 mutants Y304H and H142,143A (previously published PMID:30819897, 28927261), which will be used for validation.</p>
<p><strong>EXPERIMENTAL DESIGN:</strong></p>
<p>HEK293T cells were co-transfected for 20 h in 12 well format with 0.1 µg histone-GFP and:</p>
<p>1.empty vector (0.9 µg)</p>
<p>2.empty vector (0.1 µg) + Hdac11-FLAG (0.8 µg)</p>
<p>3.HAT-FLAG (0.1 µg) + empty vector (0.8 µg)</p>
<p>4.HAT-FLAG (0.1 µg) + Hdac11-FLAG (0.8 µg)</p>
<p><b>Histones:</b> H3, H4, H2A, H2B</p>
<p><b>HATs: </b>MYST1, P300, PCAF, GCN5</p>
<p>Total cell lysates were analysed in western blot.</p>
<p>&nbsp;</p>
<p>Fig.1</p>
<p><span style="font-size: 1.5rem;"> <img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Slide3-1-300x225.jpg" alt="" width="451" height="338" class="alignnone wp-image-3565" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Slide3-1-300x225.jpg 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Slide3-1-768x576.jpg 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Slide3-1-350x263.jpg 350w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Slide3-1-780x586.jpg 780w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Slide3-1-250x188.jpg 250w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Slide3-1.jpg 960w" sizes="(max-width: 451px) 100vw, 451px" /></span></p>
<p>Fig.2</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Slide4-1-300x225.jpg" alt="" width="453" height="340" class="alignnone wp-image-3566" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Slide4-1-300x225.jpg 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Slide4-1-768x576.jpg 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Slide4-1-350x263.jpg 350w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Slide4-1-780x586.jpg 780w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Slide4-1-250x188.jpg 250w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Slide4-1.jpg 960w" sizes="(max-width: 453px) 100vw, 453px" /></p>
<p>Fig.3</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Slide5-2-300x225.jpg" alt="" width="451" height="338" class="alignnone wp-image-3567" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Slide5-2-300x225.jpg 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Slide5-2-768x576.jpg 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Slide5-2-350x263.jpg 350w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Slide5-2-780x586.jpg 780w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Slide5-2-250x188.jpg 250w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Slide5-2.jpg 960w" sizes="(max-width: 451px) 100vw, 451px" /></p>
<p><strong>SUMMARY</strong></p>
<ul>
<li><strong>The biggest effect of HDAC11 overexpression on histones acetylation:</strong></li>
</ul>
<p><b>no HAT </b>PanAc – 4.2x<b> </b></p>
<p><b> GCN5</b> PanAc – 3.5x</p>
<p><b style="font-size: 1.5rem;">p300</b><span style="font-size: 1.5rem;"> PanAc – 2.9x</span></p>
<p><b>p300</b> H3K18Ac – 2.5x</p>
<p><b style="font-size: 1.5rem;">GCN5</b><span style="font-size: 1.5rem;"> H3K27Ac – 2.4x</span></p>
<ul>
<li><b style="font-size: 1.5rem;">HAT acetylation specificity on exogenous histones</b><b style="font-size: 1.5rem;"> in Western blot:</b></li>
</ul>
<p><b>  </b><b>MYST1:</b> H4K16 and H2A</p>
<p><b>  P300:</b> H2A&gt;H3K18&gt;H3K27</p>
<p><b>  PCAF:</b> H3K27&gt;H4K16&gt;H3K9,H3K18,H2B</p>
<p><b>  GCN5:</b>H3K27&gt;H4K16&gt;H3K9,H3K18,H2B</p>
<p>&nbsp;</p>
<p>You can find the experimental details at https://zenodo.org/record/3460636#.XYto0C5Kipo.</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/hdac11-cellular-assay-development-histones-deacetylation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Growth and Purification of Biotinylated USP5 Constructs &#038; Testing ZnF-UBD Ligands in a Displacement Assay</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/growth-and-purification-of-biotinylated-usp5-constructs-testing-znf-ubd-ligands-in-a-displacement-assay/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/growth-and-purification-of-biotinylated-usp5-constructs-testing-znf-ubd-ligands-in-a-displacement-assay/#respond</comments>
		<pubDate>Tue, 10 Sep 2019 12:54:56 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3462</guid>
		<description><![CDATA[Hi all, today’s post covers some concepts that I have previously described: expression and purification of protein constructs, and testing ligands in a displacement assay. If you’ll recall, I tried to develop and optimize a fluorescence polarization (FP) displacement assay for the ZnF-UBD of USP5 for some time but found that FP was a no <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/growth-and-purification-of-biotinylated-usp5-constructs-testing-znf-ubd-ligands-in-a-displacement-assay/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>Hi all, today’s post covers some concepts that I have previously described: expression and purification of protein constructs, and testing ligands in a displacement assay.</p>
<p>If you’ll recall, I tried to develop and optimize a <a href="https://thesgc.github.io/static-openlabnotebooks/usp5-zf-ubd-fluorescence-polarization-displacement-assay-3/">fluorescence polarization (FP) displacement assay</a> for the ZnF-UBD of USP5 for some time but found that FP was a no go to screen libraries due to a low dynamic range. For the past couple of weeks, I’ve been working on purifying biotinylated USP5 protein constructs (full-length and ZnF-UBD) to use them in a different displacement assay. You can see details of these experiments on <a href="https://zenodo.org/record/3403804#.XXeaaihKjIU"><strong>Zenodo</strong></a>.</p>
<p>I was successful in purifying various USP5 constructs with a biotin tag. I expressed and purified the constructs summarized in <strong>Table 1</strong>. Constructs 1-835 are the full length protein, while constructs 171-290 are the ZnF-UBD that I have previously crystallized in complex with my screening hits. R221A mutants were used as controls for the displacement assay. R221 is an important residue in the binding pocket of the ZnF-UBD that co-ordinates ubiquitin binding. A mutation of the arginine (R) to an alanine (A) should prevent binding of ubiquitin (and of my inhibitors) to the ZnF-UBD<sup>1,2</sup>. C335A is a mutation of the catalytic cysteine residue that carries out the cleavage of polyubiquitin chains<sup>3</sup>.</p>
<p style="text-align: center;"><strong>Table 1</strong>. USP5 construct Summary</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910a-300x137.png" alt="" width="579" height="264" class="wp-image-3463 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910a-300x137.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910a-768x351.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910a.png 872w" sizes="(max-width: 579px) 100vw, 579px" /></p>
<p>The workflow of the displacement assay is summarized in<strong> Figure 1</strong>. A biotinylated protein is captured to a streptavidin coated plate. Excess protein is removed through washes and a fluorescently labeled ubiquitin (FITC-UBQ) is displaced by a competing ligand resulting in a decrease in fluorescence after wash steps to remove unbound ligands.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910b-300x121.png" alt="" width="746" height="301" class="wp-image-3464 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910b-300x121.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910b-768x309.png 768w" sizes="(max-width: 746px) 100vw, 746px" /></p>
<p style="text-align: center;"><strong>Figure 1</strong>. Workflow of Displacement Assay</p>
<p>&nbsp;</p>
<p>I tested two ligands) in the displacement assay: unlabelled UBQ, and cpd 21 (<strong>Figure 2</strong>).</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910c-300x175.png" alt="" width="300" height="175" class="size-medium wp-image-3465 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910c-300x175.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910c.png 342w" sizes="(max-width: 300px) 100vw, 300px" /></p>
<p style="text-align: center;"><strong>Figure 2</strong>. Compound structure of cpd 21</p>
<p>Both UBQ and cpd 21 displaced FITC-UBQ from the ZnF-UBD from FL USP5 (<strong>Figure 3</strong>). A mutation of the R221 residue to an alanine resulted in no capture of FITC-UBQ and thus no displacement for UBQ and cpd 21 for both the ZnF-UBD and FL USP5.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910f-168x300.png" alt="" width="458" height="818" class="wp-image-3474 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910f-168x300.png 168w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910f-574x1024.png 574w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/20190910f.png 674w" sizes="(max-width: 458px) 100vw, 458px" /></p>
<p style="text-align: center;"><strong>Figure 3. </strong>Displacement Assay summary of a) USP5 ZnF-UBD: TOC011B06 (WT-wild type) and TOC023B06 (R221A) and b) FL USP5: TOC023A01 (WT) and TOC023A06 (R221A). HS= hill slope, NC= not calculated.</p>
<p>It should be noted these are preliminary results, and the displacement curves are still quite noisy. Sources of error could include variation of the levels of streptavidin in each well of the 384-Greiner plate. For example, there may be more protein and FITC-UBQ captured in one well over another. This is why it will be important to repeat the experiment several times before having confidence in the reported Kdisp values.</p>
<p>Nonetheless, this is an important finding for the USP5 project. ZnF-UBD ligands are able to displace ubiquitin in both the ZnF-UBD and in the full length protein. Next, I’ll be repeating the experiment several more times to tighten up the data.</p>
<p>References</p>
<p>(1)         Reyes-Turcu, F. E.; Ventii, K. H.; Wilkinson, K. D. Regulation and Cellular Roles of Ubiquitin-Specific Deubiquitinating Enzymes. <em>Annu. Rev. Biochem.</em> <strong>2009</strong>. https://doi.org/10.1146/annurev.biochem.78.082307.091526.</p>
<p>(2)         Reyes-Turcu, F. E.; Horton, J. R.; Mullally, J. E.; Heroux, A.; Cheng, X.; Wilkinson, K. D. The Ubiquitin Binding Domain ZnF UBP Recognizes the C-Terminal Diglycine Motif of Unanchored Ubiquitin. <em>Cell</em> <strong>2006</strong>. https://doi.org/10.1016/j.cell.2006.02.038.</p>
<p>(3)         Scott, D.; Layfield, R.; Oldham, N. J. Structural Insights into Interactions between Ubiquitin Specific Protease 5 and Its Polyubiquitin Substrates by Mass Spectrometry and Ion Mobility Spectrometry. <em>Protein Sci.</em> <strong>2015</strong>. https://doi.org/10.1002/pro.2692.</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/growth-and-purification-of-biotinylated-usp5-constructs-testing-znf-ubd-ligands-in-a-displacement-assay/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PROTAC Virtual Screening: A Retrospective Screening Exercise</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/protac-virtual-screening-a-retrospective-screening-exercise/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/protac-virtual-screening-a-retrospective-screening-exercise/#respond</comments>
		<pubDate>Fri, 06 Sep 2019 21:10:26 +0000</pubDate>
		<dc:creator><![CDATA[Haresh Ajani]]></dc:creator>
				<category><![CDATA[Haresh Ajani]]></category>
		<category><![CDATA[In silico PROTACs design]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3434</guid>
		<description><![CDATA[In my previous post https://thesgc.github.io/static-openlabnotebooks/protein-protein-docking-for-protac-discovery/ I showed that HADDOCK was the best protein-protein docking tool among those I tested to predict how E3 ligases interact with their protein substrates. Here, I ask whether docking virtual libraries of PROTAC candidates to these E3 ligase – substrate protein interfaces can be used to predict which PROTACs are active. <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/protac-virtual-screening-a-retrospective-screening-exercise/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p style="text-align: justify;">In my previous post <a href="https://thesgc.github.io/static-openlabnotebooks/protein-protein-docking-for-protac-discovery/">https://thesgc.github.io/static-openlabnotebooks/protein-protein-docking-for-protac-discovery/</a> I showed that HADDOCK was the best protein-protein docking tool among those I tested to predict how E3 ligases interact with their protein substrates. Here, I ask whether docking virtual libraries of PROTAC candidates to these E3 ligase – substrate protein interfaces can be used to predict which PROTACs are active.</p>
<p style="text-align: justify;">The virtual screening method that I am using is as follows (Figure 1):</p>
<ul>
<li style="text-align: justify;">Use HADDOCK to dock the E3 ligase to the protein target and keep the ~40 best solutions (typically grouped in 5 to 9 clusters of structurally related binding poses)</li>
<li style="text-align: justify;">For each PROTAC candidate, tether the two chemical handles to their corresponding ligands in the protein-protein complexes generated by HADDOCK, and minimize the energy of the PROTAC while ignoring the proteins. This produces a selection of conformationally acceptable PROTACs: SELECTION 1</li>
<li style="text-align: justify;">Start from the conformationally acceptable PROTACs (SELECTION 1) and further minimize their energy, this time accounting for the surrounding proteins (PROTACs and side-chains within 5Å are kept flexible)</li>
</ul>
<p style="text-align: justify;">Step 2 and 3 are conducted 3 times independently, and all results are merged, so, for 10 PROTAC candidates, we will have 10 molecules x 40 prot-prot-interfaces x 3 repeats = 1200 binding poses.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Screen-Shot.png" alt="" width="1261" height="746" class="alignnone size-full wp-image-3458" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Screen-Shot.png 1261w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Screen-Shot-300x177.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Screen-Shot-768x454.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Screen-Shot-1024x606.png 1024w" sizes="(max-width: 1261px) 100vw, 1261px" /></p>
<p>&nbsp;</p>
<p style="text-align: center;"><strong>Figure 1</strong>: Overview of the virtual PROTAC screen pipeline.</p>
<p>This screening pipeline is implemented in ICM (Molsoft, San Diego), and the corresponding script is attached to this <a href="https://zenodo.org/record/3403215#.XXZ-tZNKhXg">Zenodo</a> post.</p>
<p>I tested this protocol against 5 test cases taken from the literature, and the details can be found on <a href="https://zenodo.org/record/3403215#.XXZ-tZNKhXg">Zenodo</a>. Here is a summary table:</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Picture2.png" alt="" width="974" height="568" class="size-full wp-image-3438 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Picture2.png 974w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Picture2-300x175.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/09/Picture2-768x448.png 768w" sizes="(max-width: 974px) 100vw, 974px" /></p>
<p style="text-align: justify;">Two general observations can be made. First: in all test cases, the starting library of compounds for which we have experimental data is highly enriched in experimentally active molecules. Picking compounds at random, one has good chances of selecting active PROTACs. Two: in all 5 test cases, our top 3 scoring PROTACs out of the virtual screening pipeline are systematically active (see details in <a href="https://zenodo.org/record/3403215#.XXZ-tZNKhXg">Zenodo</a>). In four out of 5 test cases, the library selected by virtual screening is enriched in active PROTACs, compared with the starting library, which is better than random. At this point, it is too early to know whether this is pure luck, or whether this reflects a valid virtual screening strategy.</p>
<p style="text-align: justify;">Considering how unreliable virtual screening of conventional small molecules to a crystal structure is (one can expect 95 inactives out of 100 compounds selected virtually when the stars are aligned), it seems almost ridiculous to dock PROTACs (large and floppy molecules) to predicted protein-protein interfaces. And yet, it is not unreasonable to expect that the multiple protein-protein docking poses generated by HADDOCK (or other protein-protein docking tools), while being all suboptimal (after all, these complexes do not form naturally), are structurally sufficiently sound to be stabilized by a PROTAC. Indeed, Nowak et al. clearly showed that different PROTACs could induce different binding poses between CRBN and BRD4<sup>BD1</sup> (Nowak <em>et al</em>. <em>Nat. Chem. Biol.</em> 14:706-714). If we accept this hypothesis, the PROTAC docking step should actually be more efficient than a regular virtual screening campaign, as the orientation of the two functional ends of the PROTACs are imposed by the protein complex, which considerably reduces the conformational space available to the PROTAC, and the chances to predict a wrong PROTAC binding pose. There is still room for getting things wrong, but not as much as one would expect considering the complexity of the system.</p>
<p style="text-align: justify;">Finally, an important factor I ignored so far is that some PROTAC candidates may induce the formation of a ternary complex in a biophysical assay, but still be inactive because they do not cross cell membranes. I will probably need to incorporate physico-chemical filters to account for this, following-up on work by Maple <em>et al. ( MedChemComm., <strong>2019,</strong> DOI: 10.1039/c9md00272c)</em> and Edmondson <em>et al.</em>(<em>Bioorg. Med. Chem. Lett.,</em> <strong>2019,</strong> 13:1555-1564) Another factor even more complex is that some compounds may induce the formation of a ternary structure that is not compatible with efficient ubiquitylation of the target.</p>
<p style="text-align: justify;">Two things are sure: we need more experimentally inactive PROTACs, and there is room for improvement.</p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/protac-virtual-screening-a-retrospective-screening-exercise/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>More Purifications</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/final-purifications/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/final-purifications/#respond</comments>
		<pubDate>Wed, 28 Aug 2019 15:56:46 +0000</pubDate>
		<dc:creator><![CDATA[Jacob McAuley]]></dc:creator>
				<category><![CDATA[Huntingtin]]></category>
		<category><![CDATA[Huntington’s disease]]></category>
		<category><![CDATA[Jacob McAuley]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3393</guid>
		<description><![CDATA[Back again. Two posts in one month! I know its crazy, but I’m just excited to tell you about the progress that is being made on this project. First things first, purifications. This week I have four more to tell you about. The first is GFP, and unlike all of my other posts, this is <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/final-purifications/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>Back again. Two posts in one month! I know its crazy, but I’m just excited to tell you about the progress that is being made on this project. First things first, purifications. This week I have four more to tell you about.</p>
<p>The first is <a href="https://zenodo.org/record/3380341#.XWakIehKjcs">GFP</a>, and unlike all of my other posts, this is not because it interacts with HTT. At the moment we are trying to over express FLAG-Tagged HTT in a neuronal cell line. Growing tagged HTT is usually done in HEK293 cells although this isn&#8217;t a great cell line for physiological studies of HTT due to its improper localization. Neurons are quite a bit more sensitive, so extra care has to be taken to properly over-express this protein. Using conventional methods of over expression don’t really work due to the physical characteristics of tagged HTT, mainly its size. To get the protein into the cell we are considering following the example of Lambert, H.<em> et. al.(</em> <a href="https://doi.org/10.1139/o90-105"><em>https://doi.org/10.1139/o90-105</em></a><em>). </em>Described in this paper, is a method of electroporating cells to insert protein into the cell instead of DNA to express said protein. The GFP will be used as an optimization tool to ensure our electroporation method can successfully insert a protein into a neuronal cell.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/GFPPP-300x260.png" alt="" width="300" height="260" class="size-medium wp-image-3394 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/GFPPP-300x260.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/GFPPP.png 323w" sizes="(max-width: 300px) 100vw, 300px" /></p>
<p>&nbsp;</p>
<p>The other proteins that were purified pertained to my main project. They were P97, PIAS1, GIT1 and SP1. <a href="https://zenodo.org/record/3367290#.XWaj9OhKjcs">P97</a> was purified successfully resulting in a final yield of approximately 3 mg. <a href="https://zenodo.org/record/3380355#.XWajz-hKjcs">PIAS1</a> was unable to be successfully purified. Previously a shorter construct of PIAS1 was expressed in E. coli BL21 codon plus RIL but now we attempted an SF9 construct of full length PIAS1, although it seemed to have very poor expression in this system. GIT1 and SP1 were also unsuccessfully purified. As always, more detailed methods of purification can be found on Zenodo, any of the hyperlinks of the proteins will bring you to the respective Zenodo post.</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/final-purifications/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>More Protein Purification</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/more-protein-purification/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/more-protein-purification/#respond</comments>
		<pubDate>Tue, 13 Aug 2019 14:46:04 +0000</pubDate>
		<dc:creator><![CDATA[Jacob McAuley]]></dc:creator>
				<category><![CDATA[Huntingtin]]></category>
		<category><![CDATA[Huntington’s disease]]></category>
		<category><![CDATA[Jacob McAuley]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3320</guid>
		<description><![CDATA[Hello again! It has been a while since my last post but that is not for lack of data. Over the past month I have been purifying like crazy, adding more proteins to out bank of possible interaction partners. As we are now in the final month of the project, I want to take this <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/more-protein-purification/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>Hello again! It has been a while since my last post but that is not for lack of data. Over the past month I have been purifying like crazy, adding more proteins to out bank of possible interaction partners. As we are now in the final month of the project, I want to take this post and summarize all of the work that has been done so far.</p>
<p>This project set out with a goal of isolating putative interaction partners for use in interaction testing assays with HTT. As such, I have spent the summer harvesting and purifying proteins using different chromatography methods; including Nickel affinity and size exclusion chromatography. Below, I have an SDS analysis of all protein samples collected thus far.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/Purified-PPI-284x300.png" alt="" width="284" height="300" class="size-medium wp-image-3321 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/Purified-PPI-284x300.png 284w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/Purified-PPI.png 579w" sizes="(max-width: 284px) 100vw, 284px" /></p>
<p>To be more specific about my recent purifications; <a href="http://10.5281/zenodo.3367286">SQSTM1</a>, <a href="https://zenodo.org/record/3380353#.XWakYOhKjcs">GAPDH</a> and <a href="http://10.5281/zenodo.3367298">HIP1</a> were all recently grown and attempted to be purified. Sadly, the SQSTM1 and GAPDH resulted in no yield. SQSTM1 was expressed properly although the purification was not stringent enough, leading to an unusable product. GAPDH on the other hand seemed to have a problem with expression, unknowingly, I accidentally purified a contaminant it was discarded after Mass Spectrometry data showed it was a contaminant. HIP1 was a different story, purification by Nickel affinity and size exclusion chromatography proved successful, yielding almost 2 mg of protein. The detailed methods used of these purifications, as always, can be found on Zenodo. Each hyperlink on the protein name will take you to their respective Zenodo post.</p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/more-protein-purification/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Project Overview: Overexpressing HTT in neuronal cells</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/project-overview-overexpressing-htt-in-neuronal-cells/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/project-overview-overexpressing-htt-in-neuronal-cells/#respond</comments>
		<pubDate>Tue, 06 Aug 2019 04:19:23 +0000</pubDate>
		<dc:creator><![CDATA[Victoria Vu]]></dc:creator>
				<category><![CDATA[Huntingtin]]></category>
		<category><![CDATA[Huntington’s disease]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[Victoria Vu]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3260</guid>
		<description><![CDATA[My main project revolves around the E3 ligase UBE3A (I will be writing a project overview for this later), but I am also continuing some work in the same vein as Jolene Ho&#8217;s work looking at role of HTT in neurological disorders. HTT encodes a protein called huntingtin whose function is not known but appears <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/project-overview-overexpressing-htt-in-neuronal-cells/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>My main project revolves around the E3 ligase UBE3A (I will be writing a project overview for this later), but I am also continuing some work in the same vein as <a href="https://thesgc.github.io/static-openlabnotebooks/category/past-scientist/jolene-ho/">Jolene Ho&#8217;s work</a> looking at role of HTT in neurological disorders.</p>
<p>HTT encodes a protein called huntingtin whose function is not known but appears to be crucial to neuron function.  Mutant HTT is frequently associated with Huntington&#8217;s Disease (HD), where the 5&#8242; end of the <em>HTT</em> gene is observed to have an expanded CAG repeat region &#8211; the trinucleotide is repeated more times in individuals with HD than in normal individuals. In HD, mutant HTT is observed to affect neuronal function and structure leading to progressive neurodegeneration, however the exact disease mechanism is not well understood.</p>
<p>To study the function of HTT and the effects of mutant HTT protein <em>in vivo</em>, I will try to introduce trackable copies of <em>HTT </em>into mammalian cells, specifically neuronal cells. By overexpressing the HTT protein in varying amounts and with varying number of CAG repeats, we can try to elucidate the normal function of HTT in a non-disease context and examine how mutant HTT protein affects cell function and leads to neurodegeneration.</p>
<p>As seen in <a href="https://thesgc.github.io/static-openlabnotebooks/category/past-scientist/jolene-ho/">Jolene&#8217;s previous posts</a>, it is can be difficult to express such a large protein in cells. Jolene attempted to express HTT in <a href="https://thesgc.github.io/static-openlabnotebooks/overexpression-of-expanded-htt-in-brain-cancer-cell-lines/">two brain cancer cell lines</a>, but found limited success. I am using the same <a href="https://thesgc.github.io/static-openlabnotebooks/overexpressing-htt-in-mammalian-cells/">BacMAM virus system</a> previously established at the SGC and attempting to apply it in the widely used neuroblast cell line SH-SY5Y. The protocols for the experiments described below and additional data can be found on <a href="https://zenodo.org/record/3361015#.XUj8POhKiMo">Zenodo</a>.</p>
<p>With limited examples of the use of BacMAM in SH-SY5Y in the literature, I decided to test a range of virus amounts and included a BacMAM GFP control which I could visualize under the microscope to see how effective it was in SH-SY5Y. In line with <a href="https://thesgc.github.io/static-openlabnotebooks/overexpressing-htt-in-mammalian-cells/">Jolene&#8217;s optimization experiments</a> and a paper I found using BacMAM to overexpress wildtype and mutant LRRK2 implicated in Parkinson&#8217;s Disease  (PMID: <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429506/">22952710</a>), I used up to 25% v/v of p3 (passage 3) BacMAM virus to transduce SH-SY5Y and included HEK293 for comparison.</p>
<p>The LRRK2 article (PMID: <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429506/">22952710</a>) assayed cells for protein expression 48 hours post-transduction, so I thought I would get decent HTT expression within the same time-frame. I tracked GFP expression for 48 hours to get an overall idea of how effective the virus is in SH-SHY5. To detect HTT expression, I followed-up with FLAG-tag immunofluorescence (IF) in the SH-SY5Y (note: HEK293 don&#8217;t adhere very well and wash off easily so IF can&#8217;t be done with them). I find that GFP is very well expressed in both the HEK293 and SH-SY5Y cell lines after 48hrs, however, I did not detect any FLAG-tagged HTT in my IF (see RFP signal in figure below). This suggest that expression levels of the FLAG-tagged HTT from my BacMAM virus is likely too low to be detected using IF.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/BacMAM_HTT_48hrs-01-300x137.png" alt="" width="654" height="299" class="aligncenter wp-image-3285" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/BacMAM_HTT_48hrs-01-300x137.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/BacMAM_HTT_48hrs-01-768x350.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/BacMAM_HTT_48hrs-01-1024x467.png 1024w" sizes="(max-width: 654px) 100vw, 654px" /></p>
<p>I decided to repeat the transduction in a larger 24-well format and harvest cells for a western to see if I could detect any HTT expression. I also changed the harvest point to 3 days post-transduction as Jolene successfully in detected overexpressed HTT in HEK293 with a longer 3-day post-transduction expression period. I observed some SH-SHY5 cells began dying 2 days post-transduction, with more cells dying and lifting off in higher v/v of BacMAM virus. After 3 days, I was only able to harvest the cells with 5% BacMAM virus for my western as most of the cells at higher v/v BacMAM virus died.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/HTT_combined-01-300x148.png" alt="" width="675" height="333" class="aligncenter wp-image-3284" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/HTT_combined-01-300x148.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/HTT_combined-01-768x379.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/HTT_combined-01-1024x506.png 1024w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/HTT_combined-01.png 1338w" sizes="(max-width: 675px) 100vw, 675px" /></p>
<p>In my western, I detected FLAG-tagged HTT in the positive controls (D1 &#8211; 23 CAG repeats, D2 &#8211; 54 CAG repeats), but I did not detect any in both my SH-SY5Y grown for 3 days and 6 days post-transduction. It is possible that 5% v/v BacMAM virus is too low, but before I can move forward with higher v/v, I need to optimize conditions for the transduction in SH-SY5Y so that fewer cells die. The SH-SY5Y cells may be dying from either too much virus, the side effects of overexpressing HTT, or incompatibility with the Sf9 media the BacMAM virus is in. Moving forward, I will have to test these possibilities and optimize transduction conditions to maximize overexpression HTT while reducing cell death.</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/project-overview-overexpressing-htt-in-neuronal-cells/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Purification of the HTT C-HEAT domain</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/purification-of-the-htt-c-heat-domain/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/purification-of-the-htt-c-heat-domain/#respond</comments>
		<pubDate>Fri, 02 Aug 2019 13:40:02 +0000</pubDate>
		<dc:creator><![CDATA[Claudia Alvarez]]></dc:creator>
				<category><![CDATA[Claudia Alvarez]]></category>
		<category><![CDATA[Huntingtin]]></category>
		<category><![CDATA[Huntington’s disease]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3263</guid>
		<description><![CDATA[I am very excited to write my first post in open notebook. My post on Zenodo summarizes the results of my first ever purification of a huntingtin (HTT) domain. I was able to purify successfully the HTT C-HEAT domain encompassing residues 2088-3144. Figure 1. Anti-FLAG purification of the HTT C-HEAT domain. Eluted protein is seen <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/purification-of-the-htt-c-heat-domain/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>I am very excited to write my first post in open notebook. My post on <a href="https://zenodo.org/record/3358864#.XUQ673spA2w">Zenodo</a> summarizes the results of my first ever purification of a huntingtin (HTT) domain. I was able to purify successfully the HTT C-HEAT domain encompassing residues 2088-3144.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/C-TERM-FLAG-for-post-e1564753579324-281x300.png" alt="" class="alignnone wp-image-3269 size-medium" width="281" height="300" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/C-TERM-FLAG-for-post-e1564753579324-281x300.png 281w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/C-TERM-FLAG-for-post-e1564753579324-768x821.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/08/C-TERM-FLAG-for-post-e1564753579324.png 849w" sizes="(max-width: 281px) 100vw, 281px" /></p>
<p>Figure 1. Anti-FLAG purification of the HTT C-HEAT domain. Eluted protein is seen in the red box!</p>
<p>This purification was first done by <a href="http://labscribbles.com/">Dr. Rachel Harding</a> (<a href="https://zenodo.org/record/2628060#.XUQ4snspA2x">Zenodo</a>). Following her purification protocol, I obtained good yields of protein (0.45 mg of protein per L of Sp9 cells) which I immediately used to set crystal trays and to initiate biophysical characterization.</p>
<p>In future purifications, my aim is to improve purity as I noticed the sample was not very clean (low molecular weight proteins and nucleic acid). Further, I want to do a more stringent analysis to determine the most ideal buffer conditions for the sample using DSLS and DSF. I also would like to use SDS-PAGE and native PAGE to determine the progression of the limited proteolysis over time.</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/purification-of-the-htt-c-heat-domain/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prioritizing Commercial Analogues of Previous USP5 ZnF-UBD Hits</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/prioritizing-commercial-analogues-of-previous-usp5-znf-ubd-hits/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/prioritizing-commercial-analogues-of-previous-usp5-znf-ubd-hits/#respond</comments>
		<pubDate>Wed, 31 Jul 2019 15:38:50 +0000</pubDate>
		<dc:creator><![CDATA[Mandeep Mann]]></dc:creator>
				<category><![CDATA[Mandeep Mann]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>
		<category><![CDATA[USP5]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3242</guid>
		<description><![CDATA[Hi all, it’s been a while since my last post; I’ve been busy in the lab purifying new protein constructs, developing a new assay and expanding the chemical series of my weak binding hits for USP5 ZnF-UBD, so there will be a couple of posts coming your way in the following weeks. This week, my <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/prioritizing-commercial-analogues-of-previous-usp5-znf-ubd-hits/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>Hi all, it’s been a while since my last post; I’ve been busy in the lab purifying new protein constructs, developing a new assay and expanding the chemical series of my weak binding hits for USP5 ZnF-UBD, so there will be a couple of posts coming your way in the following weeks.</p>
<p>This week, my post focuses on my efforts to expand the chemical series against USP5 ZnF-UBD to continue to understand the structure activity relationship (SAR) and improve potency. I used GLIDE to dock commercial analogues of hit compounds DAT00000194a and DAT00000201a (Table 1) as well as fragments from my selection of ligands from my work at <a href="https://thesgc.github.io/static-openlabnotebooks/virtual-screening-with-molecular-forecaster/">Molecular Forecaster (MFI).</a> The source library for the search for analogues of DAT00000194 and DAT00000201 was Enamine’s REAL database of 700 million chemically accessible compounds. You can see details of this work on <strong><a href="https://zenodo.org/record/3356885#.XUGzoOhKjIU">Zenodo</a>.</strong></p>
<p><strong>Table 1</strong>. USP5 ZnF-UBD Hits</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/20190731a-300x119.png" alt="" width="529" height="210" class="alignnone wp-image-3243" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/20190731a-300x119.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/20190731a-768x304.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/20190731a-1024x405.png 1024w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/20190731a.png 1122w" sizes="(max-width: 529px) 100vw, 529px" /></p>
<p>20 commercial compounds were selected and ordered based on docking pose, protein-ligand interactions, docking score, chemical groups, and cost. For example, an analogue of DAT00000201a was chosen based on the hydrophobic and hydrogen bond interactions of the chemical group extending from the phenyl ring. The docked pose suggests a potential hydrogen bond interaction with residue D264 and hydrophobic interactions with residue M266 (Figure 1).</p>
<p>You can see some of the selected compounds at the end of this post, and download the sdf file!</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/20190731b-300x254.png" alt="" width="588" height="498" class="wp-image-3245 aligncenter" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/20190731b-300x254.png 300w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/20190731b-768x651.png 768w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/20190731b.png 1002w" sizes="(max-width: 588px) 100vw, 588px" /></p>
<p style="text-align: center;"><strong>Figure 1</strong>. a) Analogue of DAT00000201a b) Surface representation of USP5 ZnF-UBD with DAT00000201a (cyan) and docked pose of analogue compound (tan) [PDB: 6DXH]; c) Ribbon representation of USP5 ZnF-UBD and docked pose of analogue compound [PDB: 6DXH]</p>
<p>It’ll be interesting to see how well the analogues bind to USP5 ZnF-UBD, and how the crystallized pose of the ligands will compare to the docked pose. When the compounds arrive in a couple of weeks, I’ll be testing these compounds using a surface plasmon resonance assay. Stay tuned!</p>
<table data-upload-id="file_upload:2cbb9b40-6f73-4a3b-9e6e-1365abb845a1">
<thead>
<tr>
<th>Structure Image</th>
<th>Smiles</th>
<th>Mol. Weight</th>
</tr>
</thead>
<tbody>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>O=C([O-])CCC(=O)c1cccc(NS(=O)(=O)c2c[nH]c3ncccc23)c1</td>
<td>372.4</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>Cc1ccc(C(=O)[O-])cc1S(=O)(=O)Nc1cccc(C(=O)CCC(=O)[O-])c1</td>
<td>389.4</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>C[C@@H](CC(=O)c1cccc(-c2ccc3c(c2)CCCO3)c1)C(=O)[O-]</td>
<td>323.4</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>CN(c1ccc(S(C)(=O)=O)cc1)S(=O)(=O)c1ccc(C(=O)CCC(=O)[O-])cc1</td>
<td>424.5</td>
</tr>
<tr>
<td><img src="data:image/png;base64,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" /></td>
<td>O=C([O-])CCC(=O)c1cccc(NS(=O)(=O)c2c[nH]c(C(=O)N3CCCC3)c2)c1</td>
<td>418.5</td>
</tr>
</tbody>
</table>
<p><a href="/wp-content/uploads/2019/07/3242_f6d556eb-46ae-498f-9daf-1d06810361fe.sdf">Download SDF file</a></p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/prioritizing-commercial-analogues-of-previous-usp5-znf-ubd-hits/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Project Overview</title>
		<link>https://thesgc.github.io/static-openlabnotebooks/project-overview/</link>
		<comments>https://thesgc.github.io/static-openlabnotebooks/project-overview/#respond</comments>
		<pubDate>Wed, 24 Jul 2019 15:33:27 +0000</pubDate>
		<dc:creator><![CDATA[Claudia Alvarez]]></dc:creator>
				<category><![CDATA[Claudia Alvarez]]></category>
		<category><![CDATA[Huntingtin]]></category>
		<category><![CDATA[Huntington’s disease]]></category>
		<category><![CDATA[SGC Univ. of Toronto]]></category>

		<guid isPermaLink="false">https://thesgc.github.io/static-openlabnotebooks/?p=3212</guid>
		<description><![CDATA[I joined the group of Dr. Cheryl Arrowsmith 2 months ago. Currently, I am working on the Huntington’s disease project along with Dr. Rachel Harding and Jacob McAuley. During these past two months, I have been learning how to purify huntingtin (HTT) protein and overall getting up to date with the project. A brief introduction <a class="more-link" href="https://thesgc.github.io/static-openlabnotebooks/project-overview/">Read More ...</a>]]></description>
				<content:encoded><![CDATA[<p>I joined the group of Dr. Cheryl Arrowsmith 2 months ago. Currently, I am working on the Huntington’s disease project along with <a href="https://labscribbles.com/">Dr. Rachel Harding</a> and <a href="https://thesgc.github.io/static-openlabnotebooks/category/scientist/jacob-mcauley/">Jacob McAuley</a>. During these past two months, I have been learning how to purify huntingtin (HTT) protein and overall getting up to date with the project.</p>
<p>A brief introduction to the project: HTT is a 348 KDa protein that is vital for development <sup>1</sup>. HTT has a polyglutamine repeat at its N-terminus which is normally no longer than 35 repeats (Figure 1). When this number of repeats exceeds 38 repeats, it causes Huntington’s disease (HD), a dominantly inherited neurological disorder that occurs in adulthood and sometimes in children <sup>2</sup>. Thus, like many other neurological disorders such as Parkinson’s and Alzheimer’s disease, HD is also caused by a protein with an abnormal function in the cell. There are very limited treatments available for HD patients in part because there is little information about the function and structure of HTT and mutant HTT.</p>
<p><img src="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/Project-overview-post_3-284x300.jpg" alt="" class="alignnone size-medium wp-image-3227" width="284" height="300" srcset="https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/Project-overview-post_3-284x300.jpg 284w, https://thesgc.github.io/static-openlabnotebooks/wp-content/uploads/2019/07/Project-overview-post_3.jpg 718w" sizes="(max-width: 284px) 100vw, 284px" /></p>
<p>Figure 1. The huntingtin protein in normal population and in Huntington&#8217;s disease patients. Figure courtesy of <a href="https://labscribbles.com/">Dr. Rachel Harding</a>.</p>
<p>In the cell, HTT is thought to be involved in several important protein-protein interactions that are critical for cellular vesicular transport, endocytosis, autophagy and the regulation of transcription <sup>3,7</sup>. However, the complete picture of the function of HTT in the cell is yet not fully determined.</p>
<p>HTT is made up of three different domains. Two HEAT <sup>8,9</sup> (<u>H</u>untingtin, <u>E</u>longation factor 3, protein phosphatase 2<u>A</u>, <u>T</u>arget of rapamycin 1) domains at the N-terminus and C-terminus which are connected by a bridge. However, HTT has several disordered regions within these domains, which makes structural studies of HTT challenging. Recently, the cryo-EM structure of the protein was obtained making a huge step forward to understand more about HTT <sup>10</sup>. However, almost a quarter of the structure of HTT is still unknown in part due to the dynamic nature of this protein.</p>
<p>The main focus of my project is to obtain the 3D structure of the individual domains of the HTT protein, namely the N-terminal HEAT domain, the bridge and C-terminal HEAT domain. With this approach, we hope to better define structural elements in the protein. Further, studies with the individual domains will also be useful to understand what the role of each of the domains is within HTT. By learning about the structure and function of the individual domains, we can learn about HTT’s function inside the cell. I will be posting updates on the research progress so stay tuned!</p>
<p style="margin: 0cm; margin-bottom: .0001pt;">1. F. Saudou and S. Humbert. <em>Neuron, </em>vol. 89, no. 5, pp. 910-926, doi: <a href="https://doi.org/10.1016/j.neuron.2016.02.003">https://doi.org/10.1016/j.neuron.2016.02.003</a>.</p>
<p style="margin: 0cm; margin-bottom: .0001pt;">2. M. E. MacDonald<em> et al.</em>, &#8221; <em>Cell, </em>vol. 72, no. 6, pp. 971-983, 1993/03/26/ 1993, doi: <a href="https://doi.org/10.1016/0092-8674(93)90585-E">https://doi.org/10.1016/0092-8674(93)90585-E</a>.</p>
<p style="margin: 0cm; margin-bottom: .0001pt;">3. F. Mochel and R. G. Haller. (2011)<em>The Journal of Clinical Investigation, </em>vol. 121, no. 2, pp. 493-499, doi: <a href="https://doi.org/10.1172/JCI45691">https://doi.org/10.1172/JCI45691</a>.</p>
<p style="margin: 0cm; margin-bottom: .0001pt;">4. P. Harjes and E. E. Wanker. <em>Trends in Biochemical Sciences, </em>vol. 28, no. 8, pp. 425-433, 2003/08/01/ 2003, doi: <a href="https://doi.org/10.1016/S0968-0004(03)00168-3">https://doi.org/10.1016/S0968-0004(03)00168-3</a>.</p>
<p style="margin: 0cm; margin-bottom: .0001pt;">5. S.-H. Li and X.-J. Li, <em>The Neuroscientist, </em>vol. 10, no. 5, pp. 467-475, 2004/10/01 2004, doi: <a href="https://doi.org/10.1177/1073858404266777">https://doi.org/10.1177/1073858404266777</a>.</p>
<p style="margin: 0cm; margin-bottom: .0001pt;">6. J. P. Caviston and E. L. F. Holzbaur. <em>Trends in Cell Biology, </em>vol. 19, no. 4, pp. 147-155, 2009/04/01/ 2009, doi: <a href="https://doi.org/10.1016/j.tcb.2009.01.005">https://doi.org/10.1016/j.tcb.2009.01.005</a>.</p>
<p style="margin: 0cm; margin-bottom: .0001pt;">7. <a href="https://oxfordmedicine.com/view/10.1093/med/9780199929146.001.0001/med-9780199929146-chapter-11">Z. Chiara and C. Elena. Oxford, UK: Oxford University Press</a>.</p>
<p style="margin: 0cm; margin-bottom: .0001pt;">8. M. A. Andrade and P. Bork, <em>Nature Genetics, </em>vol. 11, no. 2, pp. 115-116, 1995/10/01 1995, <a href="https://doi.org/10.1038/ng1095-115">doi: 10.1038/ng1095-115</a>.</p>
<p style="margin: 0cm; margin-bottom: .0001pt;">9. J. Perry and N. Kleckner,  <em>Cell, </em>vol. 112, no. 2, pp. 151-155, 2003, doi: <a href="https://doi.org/10.1016/S0092-8674(03)00033-3">10.1016/S0092-8674(03)00033-3</a>.</p>
<p style="margin: 0cm; margin-bottom: .0001pt;">10. Q. Guo<em> et al.</em>, <em>Nature, </em>vol. 555, no. 7694, pp. 117-+, Mar 2018, <a href="https://doi.org/10.1038/nature25502">doi: 10.1038/nature25502</a>.</p>
]]></content:encoded>
			<wfw:commentRss>https://thesgc.github.io/static-openlabnotebooks/project-overview/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
